Skip to main content
TipRanks
Go Ultimate75% OFF

Brian Halak Insider Profile

4 Followers

Brian Halak, Ten Percent Owner at Veracyte, holds 327.00 shares in Alimera (Ticker: ALIM), holds 2.61M shares in Dicerna Pharma (Ticker: DRNA), holds 0.00 shares in Cadence Pharma (Ticker: CADX).

Brian Halak's Trading History

ALIM
Alimera
Sep 17, 2021―Uninformative Buy―$1.81K
DRNA
Dicerna Pharma
Nov 06, 2018―Informative Sell4.46M$99.59M
CADX
Cadence Pharma
Mar 21, 2014―Uninformative Sell42.71M―
AKAOQ
Achaogen
Mar 17, 2014―Uninformative Buy―$847.25
VCYT
Veracyte
Nov 04, 2013Ten Percent OwnerUninformative Buy―$553.02K
EVOK
Evoke Pharma
Sep 30, 2013―Uninformative Buy―$266.82K
TBRA
Tobira Therapeutics
Aug 21, 2013―Informative Buy―$722.73K
OCRX
Ocera Therapeutics
Jul 15, 2013―Informative Buy7.99M$6.31M
ESPR
Esperion
Jul 02, 2013―Uninformative Buy―$112.10K
~ACHN
Achillion Pharmaceuticals
Jan 18, 2013―Uninformative Sell―$1.65M
CLPM
Celator Pharmaceuticals
Jan 14, 2013―Informative Buy―$177.45K
DRTX
Durata
Jul 24, 2012―Uninformative Buy――
OREXQ
Orexigen
Dec 22, 2011―Informative Buy680.26K$253.22
CLVSQ
Clovis Oncology
Nov 21, 2011―Uninformative Buy―$765.20
ZGNX
Zogenix
Sep 20, 2011―Informative Buy7.00M$4.52M
VNDA
Vanda
Mar 29, 2010DirectorUninformative Buy―$29.03K
VOLC
Volcano Corp
――――
PRTK
Paratek Pharmaceuticals
―――$223.79K

You May Also Like

Brian Halak insider profile FAQ

What is the percentage of profitable transactions made by Brian Halak?
The percentage of profitable transactions made by Brian Halak is 0%.
What is the average return per transaction made by Brian Halak?
The average return per transaction made by Brian Halak is -24.50%.
What stocks does Brian Halak hold?
Brian Halak holds: VCYT, DRNA, ALIM, OCRX, CLVSQ, ZGNX, ~ACHN, ESPR, AKAOQ, TBRA, OREXQ, VNDA, EVOK, CLPM, CADX, PRTK, VOLC, DRTX stocks.
What was Brian Halak's most profitable transaction?
Brian Halak’s most profitable transaction was an Informative Sell of DRNA stock on November 6, 2018. The return on the trade was -20.50%.
What is Brian Halak's role in Veracyte?
Brian Halak's role in Veracyte is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.